ReviewJournal of obesity & metabolic syndrome2023

Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the Horizon.

Eonju Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.